canagliflozin


Also found in: Medical, Wikipedia.
Translations

canagliflozin

n canagliflozina
References in periodicals archive ?
J&J said it is recruiting for Phase III clinical trials which it expects will involve more than 10,000 patients with Type 2 diabetes, including a lengthy study to demonstrate that canagliflozin does not increase heart attack or stroke risk.
The coming years will see Japan pharma regaining its status as innovator driven with Edoxaban for Daiichi Sankyo, Canagliflozin for Mitsubishi Tanabe, and Dolutegravir for Shionogi bringing the good times back for the respective companies in 2013 and carrying enough potential to change global market dynamics in the anticoagulant, diabetes and HIV space resp.
The Food and Drug Administration has issued a new warning and precaution for the type 2 diabetes drug canagliflozin, saying that risks of decreased bone density associated with the drug are more serious than previously stated.
announced today that both companies would launch CANAGLU 100mg tablets (generic name: canagliflozin hydrate, hereafter, CANAGLU), for a treatment for type 2 diabetes mellitus, in Japan on September 3, 2014, following today s inclusion of CANAGLU in the National Health Insurance drug price list.
com/research/2qlc2k/lexicons_lx4211) has announced the addition of the "Lexicon's LX4211 - FDA canagliflozin decision is key bellweather" report to their offering.
The most recent studies of this newest class of oral antidiabetes drugs find that in addition to glucose lowering effects, empagliflozin, dapagliflozin, and canagliflozin also promote weight loss and reduce blood pressure in patients with type 2 diabetes.
BERLIN--Treatment of type 2 diabetes patients with canagliflozin, an investigational drug that boosts urinary glucose excretion, produced a clear rise in glycemic control while also dropping blood pressure and weight, compared with the established agent sitagliptin, in a phase III study with 755 patients.
SGLT-2 inhibitors: The recently launched SGLT-2 inhibitors are experiencing rapid uptake in the major markets, despite known associations with genital mycotic and urinary tract infections; the first-to-market entrants canagliflozin (Johnson & Johnson's Invokana) and dapagliflozin (AstraZeneca's Farxiga/Forxiga) are set to garner significant sales.
Food and Drug Administration (FDA) for INVOKAMET(TM), a fixed-dose therapy combining canagliflozin and metformin hydrochloride in a single tablet, for the treatment of adults with type 2 diabetes.
a fixed-dose therapy combining canagliflozin and immediate release metformin hydrochloride in a single tablet for the treatment of adults with type 2 diabetes; OLYSIO[sup.
This appears to be a unique property of active remogliflozin, which also demonstrated greater than ten times the antioxidant activity of canagliflozin and dapagliflozin when measured by oxygen radical antioxidant capacity in vitro.
on key health measures for older people with type 2 diabetes," said Norman Rosenthal, MD, FACE, FACP, canagliflozin compound development team leader, Janssen.